Chen Yingxiang, Zhang Cui, Zou Xiang, Yu Miao, Yang Bo, Ji Chen-Feng, Gao Shi-Yong, Li Jun, Liu Bin
Engineering Research Center for Medicine, Harbin University of Commerce, Harbin, 150076, China.
College of Pharmacy, Harbin University of Commerce, No. 138 Tongda Street, Harbin, 150076, Heilongjiang Province, China.
BMC Med Genomics. 2021 Jun 13;14(1):159. doi: 10.1186/s12920-021-01010-0.
Recent scientific research has enabled the identification of macrophages related-genes (MaRG), which play a key role in the control of the immune microenvironment in many human cancers. However, the functional role of MaRGs in human tumors is ill-defined. Herein, we aimed at bioinformatically exploring the molecular signatures of MaRGs in colorectal cancer.
A list of MaRGs was generated and their differential expression was analyzed across multiple datasets downloaded from the publicly available functional genomics database Gene Expression Omnibus. The weighted gene co-expression network analysis (WGCNA) was also applied to identify the partner genes of these MaRGs in colorectal cancer.
After integration of the results from analyses of different datasets, we found that 29 differentially expressed MaRGs (DE-MaRGs) could be considered as CRC-related genes as obtained from the WGCNA analysis. These genes were functionally involved in positive regulation of DNA biosynthetic process and glutathione metabolism. Protein-protein interaction network analysis indicated that PDIA6, PSMA1, PRC1, RRM2, HSP90AB1, CDK4, MCM7, RFC4, and CCT5 were the hub MaRGs. The LASSO approach was used for validating the 29 MaRGs in TCGA-COAD and TCGA-READ data and the results showed that ten among the 29 genes could be considered as MaRGs significantly involved in CRC. The maftools analysis showed that MaRGs were mutated at varying degrees. The nomogram analysis indicated the correlation of these MaRGs with diverse clinical features of CRC patients.
Conclusively, the present disclosed a signature of MaRGs as potential key regulators involved in CRC pathogenesis and progression. These findings contribute not only to the understanding of the molecular mechanism of CRC pathogenesis but also to the development of adequate immunotherapies for CRC patients.
近期的科学研究已能够鉴定出巨噬细胞相关基因(MaRG),这些基因在许多人类癌症的免疫微环境控制中发挥关键作用。然而,MaRG在人类肿瘤中的功能作用尚不明确。在此,我们旨在通过生物信息学方法探索MaRG在结直肠癌中的分子特征。
生成一份MaRG列表,并分析其在从公开可用的功能基因组数据库基因表达综合数据库下载的多个数据集中的差异表达。加权基因共表达网络分析(WGCNA)也被用于鉴定这些MaRG在结直肠癌中的伙伴基因。
整合不同数据集的分析结果后,我们发现29个差异表达的MaRG(DE-MaRG)可被视为通过WGCNA分析获得的与结直肠癌相关的基因。这些基因在DNA生物合成过程的正调控和谷胱甘肽代谢中发挥功能作用。蛋白质-蛋白质相互作用网络分析表明,PDIA6、PSMA1、PRC1、RRM2、HSP90AB1、CDK4、MCM7、RFC4和CCT5是核心MaRG。LASSO方法用于在TCGA-COAD和TCGA-READ数据中验证这29个MaRG,结果表明这29个基因中有10个可被视为显著参与结直肠癌的MaRG。maftools分析表明MaRG存在不同程度的突变。列线图分析表明这些MaRG与结直肠癌患者的多种临床特征相关。
总之,本研究揭示了MaRG作为参与结直肠癌发病机制和进展的潜在关键调节因子的特征。这些发现不仅有助于理解结直肠癌发病机制的分子机制,也有助于为结直肠癌患者开发适当的免疫疗法。